Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.715,68
-0,13%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cingulate Inc (CINGW) Cingulate Inc (CINGW) Notizie

Cingulate Inc

CINGW
0,0218
0,0002 (0,93%)
10 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Warrant Azionario
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/5/202413:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:10EDGAR2Form 8-K - Current report
08/5/202413:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
30/4/202411:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
16/4/202423:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
01/4/202414:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
19/3/202421:45GLOBECingulate to Participate in Benzinga All Live Access Event
06/3/202412:45GLOBECingulate to Attend DCAT Week 2024 in New York City
13/2/202412:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
06/2/202422:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
02/2/202415:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
29/1/202414:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
29/1/202412:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
01/12/202315:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
13/11/202322:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
17/10/202320:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
21/9/202319:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
13/9/202322:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
11/9/202315:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
11/9/202312:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
08/9/202322:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
05/9/202314:00GLOBECingulate Announces Presentation of Full Trial Results from..
14/8/202322:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
11/7/202314:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
29/6/202314:00GLOBECingulate Successfully Manufactures Clinical Supply –..
14/6/202321:45GLOBECingulate to Participate in the Healthcare Virtual..
08/6/202313:00GLOBECingulate Completes Phase 3 Adult Trial of CTx-1301..
25/5/202321:55GLOBECingulate to Present at 13th Annual LD Micro Invitational
12/5/202321:45GLOBECingulate, Indegene to Participate in Benzinga All Live..
Apertura: 0,0218 Min: 0,0218 Max: 0,0218
Chiusura: 0,0216

La tua Cronologia

NASDAQ
CINGW
Cingulate
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network